View Filing Data

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2014	Aug. 06, 2014
Document And Entity Information
Entity Registrant Name	Nxt-ID, Inc.
Entity Central Index Key	0001566826
Amendment Flag	true
Amendment Description	<p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: center;"><b>EXPLANATORY NOTE</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">Nxt-ID, Inc. (the “Company”) is filing this Amendment No. 1 to its Quarterly Report on Form 10-Q (this “Amendment”) to amend and restate its Quarterly Report on Form 10-Q for the period ended June 30, 2014, originally filed on August 8, 2014 (the “Original Filing”). </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><b> </b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><b>Background to the Restatement</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">During the preparation of the Company’s Quarterly Report on Form 10-Q for the period ending September 30, 2014, The Company and the Audit Committee of the Company’s Board of Directors (the “Audit Committee”) identified an accounting error and a computational error in the condensed consolidated financial statements as of June 30, 2014.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The Company and the Audit Committee determined that it was necessary to correct the accounting error for certain warrants as presented within the statement of operations along with a corresponding impact on the Company’s condensed consolidated financial statements for the period ended June 30, 2014. In addition, the Company also corrected the computational error. The impact on the Company’s condensed consolidated financial statements for the period ended June 30, 2014 resulted in a net loss for the six and three months ended June 30, 2014 of $2,228,915 and $2,090,546 respectively, compared to the previously reported loss of $3,822,887 and $2,227,435.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The non-cash adjustments primarily relate to the February 2014 determination of the fair value of derivatives associated with the Company’s warrants issued in December 2013 and January 2014 and inducement expense on warrants reissued in June 2014. The amendment and restatement of these values resulted in the revision of charges reported in the Original Filing aggregating $2,232,337 and $1,177,760, respectively, for the six and three months ended June 30, 2014, to charges aggregating $638,365, and $1,051,128, respectively, as a result of these corrections. The Company also reduced the amount of operating expenses for the three months ended June 30, 2014 by $10,257 from the previously reported amount of $1,049,675 to $1,039,418. The net loss for the six and three months ended June 30, 2014, was revised to $2,228,915 and $2,090,546, respectively, compared to the previously reported loss of $3,822,887 and $2,227,435, respectively. Total assets, total liabilities and total stockholders’ equity at June 30, 2014 were unchanged as a result. Further, cash flows including cash flows from operating activities for the six months ended June 30, 2014 were also unchanged. These errors did not impact the Company’s results of operations or our financial position as of or for any period prior to January 1, 2014. </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><b>Effects of Restatement</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><font style="background-color: white;">This Amendment amends and restates Item 1 (Financial Statements) and Item 2 (</font>Management’s Discussion and Analysis of Financial Condition and Results of Operations)<font style="background-color: white;"> of Part I of the Original Filing, as necessary based on the restatement of the Company’s condensed consolidated financial statements. Additionally, this Amendment replaces the interactive data files required by Item 601(b)(101) of Regulation S-K and Sections 405 and 406T of Regulation S-T, that were initially filed on the Original Filing. As required pursuant to the Securities and Exchange Act of 1934, as amended, this Amendment also includes updated certifications from the Company’s Chief Executive Officer and Chief Financial Officer as Exhibits 31.1, 31.2, 32.1 and 32.2.</font></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">Except as described above or the specific events of a later date as disclosed in Item 2, this Amendment does not amend, update or change any other items or disclosures in the Original Filing and does not purport to reflect any information or events subsequent to the filing thereof. Accordingly, this Amendment should be read in conjunction with the Original Filing.</p>
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Jun. 30, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q2
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		22,044,347

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2014	Dec. 31, 2013
Current Assets
Cash	$ 588,179	$ 303,626
Restricted cash	4,152
Inventory	29,567	6,533
Prepaids	95,041	3,313
Total Current Assets	716,939	313,472
Property and equipment, net of accumulated depreciation of $1,944 and $684	23,209	7,734
Total Assets	740,148	321,206
Current Liabilities
Accounts payable	92,804	244,094
Accrued expenses	53,490	135,017
Customer deposits	80,075
Convertible notes payable, net of discount of $0 and 26,755, respectively		123,245
Derivative liability - warrants		1,531,303
Conversion feature liability		118,940
Total Current Liabilities	226,369	2,152,599
Commitments and Contingencies
Stockholders' Equity (Deficiency)
Preferred stock, $0.0001 par value: 10,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value: 100,000,000 shares authorized; 22,028,285 and 21,937,822 issued and outstanding, respectively	2,203	2,194
Additional paid-in capital (deficit)	4,493,901	(80,177)
Accumulated deficit	(3,982,325)	(1,753,410)
Total Stockholders' Equity (Deficiency)	513,779	(1,831,393)
Total Liabilities and Stockholders' Equity (Deficiency)	$ 740,148	$ 321,206

Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - USD ($)	Jun. 30, 2014	Dec. 31, 2013
Balance Sheets [Abstract]
Accumulated Depreciation	$ 1,944	$ 684
Net of discount of convertible notes payable	$ 0	$ 26,755
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Authorized	10,000,000	10,000,000
Preferred Stock, Issued
Preferred Stock, Outstanding
Common Stock, Par Value	$ 0.0001	$ 0.0001
Common Stock, Authorized	100,000,000	100,000,000
Common Stock, Issued	22,028,285	21,937,822
Common Stock, Outstanding	22,028,285	21,937,822

Condensed Consolidated Statements Of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Statements of Operations [Abstract]
Revenues
Costs of goods sold
Gross Profit
Operating Expenses
General and administrative	462,151	67,536	758,077	326,004
Selling and marketing	317,419	489	377,603	5,489
Research and development	259,848	84,224	424,126	262,007
Total Operating Expenses	1,039,418	152,249	1,559,806	593,500
Operating Loss	(1,039,418)	(152,249)	(1,559,806)	(593,500)
Other Expense
Interest and other expenses, net		(4,500)	(30,744)	(8,250)
Inducement expense in connection with warrant exercise	(1,051,128)		(1,051,128)
Unrealized gain on change in fair value of derivative liabilities			412,763
Total Other Expense	(1,051,128)	(4,500)	(669,109)	(8,250)
Net Loss	$ (2,090,546)	$ (156,749)	$ (2,228,915)	$ (601,750)
Net Loss Per Common Share - Basic and Diluted	$ (0.09)	$ (0.01)	$ (0.10)	$ (0.03)
Weighted Average Number of Common Shares Outstanding - Basic and Diluted	22,054,704	21,242,244	22,011,401	21,109,011

Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash Flows from Operating Activities
Net loss	$ (2,228,915)	$ (601,750)
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation	1,260	198
Stock based compensation	144,000	80,000
Amortization of debt discount	26,755
Unrealized gain on change in fair value of derivative liabilities	(412,763)
Inducement fee in connection with warrant exercise	1,051,128
Changes in operating assets and liabilities:
Inventory	(23,034)	(2,790)
Prepaids	(91,728)
Accounts payable	(151,290)	219,907
Accrued expenses	(60,042)
Customer deposits	80,075
Total Adjustments	564,361	297,315
Net Cash Used in Operating Activities	(1,664,554)	(304,435)
Cash flows from Investing Activities
Restricted Cash	(4,152)
Purchase of equipment	(16,735)
Net Cash Used in Investing Activities	(20,887)
Cash flows from Financing Activities
Proceeds received in connection with issuance of common stock and warrants, net	799,994
Proceeds received in connection with issuance of common stock, net		246,435
Proceeds received in connection with exercise of warrants	1,170,000
Proceeds from convertible notes payable		75,000
Proceeds from advances made by officer		64,000
Repayments of advances made by officer		(60,000)
Net Cash Provided by Financing Activities	1,969,994	325,435
Net Increase in Cash	284,553	21,000
Cash - Beginning of Period	303,626	135,820
Cash - End of Period	588,179	156,820
Supplemental Disclosures of Cash Flow Information:
Interest
Taxes
Non-cash financing activities:
Recognition of liability in connection with warrant issuance	3,450,976
Reclassification of warrant liability to additional paid-in capital in connection with warrant modification	4,589,734
Issuance of common stock in connection with conversion of note payable and accrued interest	171,485
Reclassification of conversion feature liability in connection with note conversion	98,722
Retirement of common stock by officers	68
Accrual of common shares to be issued for services		$ 35,000

Summary of Significant Accounting Policies	6 Months Ended
Summary of Significant Accounting Policies	Jun. 30, 2014
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Note 4 - Summary Of Significant Accounting Policies *Use of Estimates in the Financial Statements* The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. *Principles of Consolidation* The consolidated financial statements include the accounts of Nxt-ID and its wholly-owned subsidiary, 3D-ID. Intercompany balances and transactions have been eliminated upon consolidation. *Restricted Cash* Restricted cash is comprised of amounts held by credit card processors until the Company establishes a history of activity and the processor is able to estimate potential charge back risk. The balances are rolling and held by the processor for a period of less than a year and therefore reported as a current asset on the accompanying condensed consolidated balance sheets. *Inventory* Inventory consists principally of raw materials and is valued at the lower of cost or market with cost determined using the first-in, first-out method and with market defined as the lower of replacement cost or realizable value. As of June 30, 2014 inventory is comprised of $29,567 in raw materials on hand. In addition, as an early stage entity, the Company is required to prepay for raw materials with certain vendors until credit terms can be established. As of June 30, 2014, $86,600 of prepaid inventory is included in prepaids on the condensed consolidated balance sheet. *Revenue Recognition* The Company’s 3D facial recognition and identification products are currently available for sale and the Company has begun accepting pre-orders on its Mobile Bio Wocket. The Company recognizes revenue in connection with the sale of these products when persuasive evidence of an arrangement exists, the service has been rendered or product delivery has occurred, the price is fixed or readily determinable and collectability of the sale is reasonably assured. As of June 30, 2014, the Company has received $80,075 in customer deposits in connection with pre-orders of its MobileBio Wocket. *Convertible Instruments* The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion options. The accounting standards require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (i) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The derivative is subsequently marked to market at each reporting date based on current fair value, with the changes in fair value reported in the results of operations. Conversion options that contain variable settlement features, such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract, generally result in their bifurcation from the host instrument. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 “Debt with Conversion and Other Options.” The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt. See Note 5 below. *Debt discount and amortization of debt discount* Debt discount represents the fair value of embedded conversion options of various convertible debt instruments and attached convertible equity instruments issued in connection with debt instruments. The debt discount is amortized over the earlier of (i) the term of the debt or (ii) conversion of the debt. The amortization of debt discount is included as a component of interest and other expenses, net in the accompanying statements of operations. *Income Taxes* The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, "Income Taxes." Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity's financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if, based on the weight of the available positive and negative evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. ASC Topic 740-10-30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740-10-40 provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company will classify as income tax expense any interest and penalties. The Company has no material uncertain tax positions for any of the reporting periods presented. Generally, the tax authorities may examine the partnership/corporate tax returns for three years from the date of filing. The Company is in the process of filing its tax returns for the year ended December 31, 2013. Therefore, the Company’s net operating loss carryovers will not be available to offset future taxable income, if any, until the returns are filed. *Stock-Based Compensation* The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Non-employee stock-based compensation charges are amortized over the vesting period or as earned. *Net Loss per Share* Basic loss per share was computed using the weighted average number of common shares outstanding. Diluted loss per share includes the effect of diluted common stock equivalents. Potentially dilutive securities realizable from the exercise of 1,396,139 warrants as of June 30, 2014 were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. As of June 30, 2013, potentially dilutive securities realizable from the conversion of the Company’s then outstanding note payable into 120,000 shares of common stock and the exercise of warrants for the purchase of 304,600 common shares were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. *Research and Development* Research and development costs consist of expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge that would be useful in developing new products or processes. The Company expenses all research and development costs as incurred.

Stockholders' Equity

6 Months Ended

Jun. 30, 2014

Stockholders' Equity [Abstract]

STOCKHOLDERS' EQUITY

Note 6 - Stockholders' Equity

On January 13, 2014, the Company closed a “best efforts” private offering of $1,000,000 (the “Offering”) with a group of accredited investors (the “Purchasers”) and the Company exercised the oversubscription amount allowed in the Offering of $350,000, for total gross proceeds to the Company of $1,350,000 before deducting placement agent fees and other expenses. Pursuant to a securities purchase agreement with the Purchasers (the “Purchase Agreement”), the Company issued to the Purchasers (i) 415,387 shares of the Company’s common stock, par value $0.0001 and (ii) 1,350,000 warrants (the “Warrants”) to purchase shares (the “Warrant Shares”) of the Company’s common stock at an exercise price of $3.25 per share. In connection with the Offering, 138,463 units were sold at the end of December 2013 and 276,924 units were sold in January 2014, all at $3.25 per unit. As a result, the Company received aggregate gross proceeds of $450,000 in December 2013 from the issuance of 138,463 shares of common stock and 450,000 Warrants, and the Company received $900,000 in January 2014 from the issuance of 276,924 shares of common stock and 900,000 Warrants. Costs incurred associated with the Offering in December 2013 and January 2014 were $56,820 and $100,006, respectively. In January 2014, the placement agent received 41,539 Warrants from the Offering.

Pursuant to the Purchase Agreement, the Company’s founders who are members of management (the “Founders”) agreed to cancel a corresponding number of shares to those shares issued in the Offering and place in escrow a corresponding number of shares to be cancelled for each Warrant Share issued. As a result, the Founders retired 138,463 and 276,924 shares of common stock in December 2013 and January 2014, respectively.

The Warrants are exercisable for a period of five (5) years from the original issue date. The initial exercise price with respect to the Warrants was $3.25 per share. On the date of issuance, the Warrants were recognized as derivative liabilities as they did not have fixed settlement provisions because their exercise prices could be lowered if the Company was to issue securities at a lower price in the future. As a result, the Company recorded $3,450,976 as derivative liability warrants on the condensed consolidated balance sheet on January 13, 2014.

On February 21, 2014, the Company amended the terms of the 1,391,539 Warrants issued in the Offering to eliminate the anti-dilution provision and to lower the exercise price of the Warrants from $3.25 to $3.00. As a result of the Warrant modifications, the Company re-measured the Warrant liability on the modification date and recorded an unrealized gain on derivative liabilities of $392,545 and reclassified the aggregate re-measured value of the Warrants of $4,589,734 to additional paid-in capital. See Note 7 below.

On various dates, during the six months ended June 30, 2014, the Company received gross proceeds of $1,200,000 in connection with the exercise of 400,000 warrants into 400,000 shares of common stock at an exercise price of $3.00 per share, net of fees to be paid upon the exercise of the warrants issued in the Offering per the term of the underwriter agreement of $30,000. Upon exercise, pursuant to the Purchase Agreement, the Company’s Founders cancelled a corresponding number of shares for each Warrant Share issued. As a result, the Founders retired 400,000 shares of common stock.

From June 12, 2014 to June 17, 2014, the Company conducted a private offering with a group of accredited investors (the “Purchasers”) who had previously participated in the Offering that occurred between December 30, 2013 and January 13, 2014 (as discussed in this Note 6). Pursuant to a securities purchase agreement with the Purchasers, the Company issued to the Purchasers warrants (the “June Warrants”) to purchase an aggregate of 400,000 shares (the “June Shares”) of the Company’s common stock at an exercise price of $3.00 per share. The Warrants are exercisable for a period of (5) five years from the original issue date. The exercise price for the June Warrants is subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate change and dilutive issuances. The Company determined that the effect of the issuance of the warrants was to induce the Purchasers to exercise warrants previously issued to them in the Offering. As a result, the Company recorded an inducement expense of $1,051,128 for the six and three months ended June 30, 2014.

In connection with the sale of the June Warrants, the Company entered into a registration rights agreement with the Purchasers pursuant to which the Company agreed to register the Shares and the shares of the common stock underlying the June Warrants (the “June Registrable Securities”) on a Form S-1 registration statement (the “June Registration Statement”) to be filed with the SEC ninety (90) days following the completion of an underwritten public offering (the “Filing Date”) and to cause the June Registration Statement to be declared effective under the Securities Act within 90 days following the Filing Date (the “Required Effective Date”).

If the Registration Statement is not filed by the Filing Date or declared effective by the Required Effective Date, the Company is required to pay partial liquidated damages to each Purchaser in the amount equal to 2% for the purchase price paid for the Warrants then owned by such Purchaser for each 30-day period for which the Company is non-compliant.

The following table summarizes the Company's warrants outstanding and exercisable at June 30, 2014:

						Weighted
				Weighted		Average
				Average		Remaining
	Number of			Exercise		Life		Intrinsic
	Warrants			Price		In Years		Value
Outstanding at December 31, 2013		454,600		$	3.23		4.97	$	351,300
Issued		1,341,539			3.00		-
Exercised		(400,000	)		3.00		-
Cancelled		-			-		-
Outstanding at June 30, 2014		1,396,139		$	2.99		4.49	$	1,279,686
Exercisable at June 30, 2014		1,396,139		$	2.99		4.49	$	1,279,686

On January 4, 2013, a majority of the Company’s stockholders approved by written consent the Company’s 2013 Long-Term Stock Incentive Plan (“LTIP”). The maximum aggregate number of shares of common stock that may be issued under the LTIP, including stock awards and stock appreciation rights, is limited to 10% of the shares of common stock outstanding on the first business or trading day of any fiscal year, which is 2,193,782 at January 1, 2014. During the six and three months ended June 30, 2014, the Company issued 5,084 and 2,558 restricted shares, respectively, under the plan to two non-executive directors with an aggregate fair value of $20,000 and $10,000, respectively. For the six months ended June 30, 2014, the Company issued 29,883 shares of common stock with an aggregate fair value of $124,000 to consultants for services rendered to the Company. The Company did not issue any common stock to employees during the six months ended June 30, 2014.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph d
-Article 4

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

Derivative Liabilites

6 Months Ended

Jun. 30, 2014

Derivative Liabilities [Abstract]

DERIVATIVE LIABILITIES

Note 7 – Derivative liabilities

Fair value of financial instruments is defined as an exit price, which is the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date. The degree of judgment utilized in measuring the fair value of assets and liabilities generally correlates to the level of pricing observability. Financial assets and liabilities with readily available, actively quoted prices or for which fair value can be measured from actively quoted prices in active markets generally have more pricing observability and require less judgment in measuring fair value. Conversely, financial assets and liabilities that are rarely traded or not quoted have less price observability and are generally measured at fair value using valuation models that require more judgment. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency of the asset, liability or market and the nature of the asset or liability. The Company has categorized its financial assets and liabilities measured at fair value into a three-level hierarchy.

The conversion feature embedded within the Company’s convertible notes payable and the warrants issued in connection with the Offering (as defined in Note 6 above) did not have fixed settlement provisions on the dates they were initially issued because the conversion and exercises prices could have been lowered if the Company would have issued securities at lower prices before conversion.

The derivative liabilities were valued using the Black-Scholes option valuation model and the following weighted average assumptions on the following dates:

	February 21, 2014			February 18, 2014			January 13, 2014
Embedded Conversion Feature and Warrant Liability:
Risk-free interest rate		1.52	%		.10	%		1.60	%
Expected volatility		105.36	%		105.36	%		123.54	%
Expected life (in years)		4.88			0.75			5.00
Expected dividend yield		-			-			-
Number of shares		1,391,539			55,497			941,539
Fair value	$	4,589,734		$	98,722		$	3,450,976

The risk-free interest rate was based on rates established by the Federal Reserve. Since the Company’s common stock has not been publicly traded for a sufficiently long period of time, the Company is utilizing an expected volatility figure based on a review of the historical volatilities, over a period of time, equivalent to the expected life of the instrument being valued, of similarly positioned public companies within its industry. The expected life of the conversion feature was determined by the maturity date of the Note (as defined in Note 5) and the expected life of the Warrants was determined by their expiration dates. The expected dividend yield was based upon the fact that the Company has not historically paid dividends on its common stock and does not expect to pay dividends on its common stock in the future.

Fair Value Measurement

Valuation Hierarchy

ASC 820, “Fair Value Measurements and Disclosures,” establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The Company had no liabilities carried at fair value measured on a recurring basis as of June 30, 2014.

The carrying amounts of cash, inventory, prepaid expenses, accounts payable and accrued liabilities approximate their fair value due to their short maturities. The Company’s other financial instruments included its convertible notes payable obligations. The carrying value of these instruments approximated fair value, as they bear terms and conditions comparable to market for obligations with similar terms and maturities. The Company measures the fair value of financial assets and liabilities based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value.

Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s accounting department, who reports to the Principal Financial Officer, determines its valuation policies and procedures. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s accounting department and are approved by the Principal Financial Officer.

Level 3 Valuation Techniques

Level 3 financial liabilities consisted of the conversion feature liability and common stock purchase warrants for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. A significant decrease in the volatility or a significant decrease in the Company’s stock price, in isolation, would result in a significantly lower fair value measurement.

As of June 30, 2014, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.

The following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis:

	For the Six Months Ended			For the Six and Three Months Ended
	June 30, 2014			June 30, 2013
Beginning liability balance	$	1,650,243		$	-
Recognition of derivative value in equity		3,450,976			44,966
Net unrealized gain on derivative liabilities in equity		(392,545	)		-
Net unrealized gain on conversion feature liabilities		(20,218	)		(1,642	)
Adjustment to additional paid-in capital upon conversion and modification		(4,688,456	)		-
Ending balance	$	-		$	43,324

Commitments and Contingencies

6 Months Ended

Jun. 30, 2014

Commitments and Contingencies [Abstract]

COMMITMENTS AND CONTINGENCIES

Note 8 - Commitments and Contingencies

Legal Matters

From time to time, the Company is subject to legal proceedings arising in the ordinary course of business. Such matters are subject to uncertainties and outcomes are not predictable with assurance. Management believes at this time that there are no ongoing matters that will have a material adverse effect on the Company's business, financial position, results of operations, or cash flows.

Commitments

In October 2012, the Company entered into an agreement with a consultant to provide public relations and marketing services to the Company. Pursuant to the agreement, the Company agreed to pay the consultant a monthly cash retainer of $5,000 and to issue the consultant shares of common stock per month with a fair value of $10,000 as compensation for services provided. In addition to the monthly retainer, the consultant is to be reimbursed for other expenses incurred in connection with certain marketing events The Company entered into a new agreement with this consultant on November 1, 2013 for a period of six (6) months and agreed to pay the consultant a monthly cash retainer of $5,000. On July 1, 2014, the Company entered into a new twelve (12) month agreement with the consultant. The Company agreed to pay the consultant a monthly cash retainer of $5,000 and to issue the consultant shares of common stock per month with a fair value of $10,000 as compensation for services provided. During the six and three months ended June 30, 2014, the Company paid the consultant $162,767 and $112,640, respectively pursuant to this agreement. Also during the six and three months ended June 30, 2014, 2,445 and 2,445 shares of common stock, respectively, with a fair value of $10,000 and $10,000, respectively, were paid to the consultant as compensation for services provided. During the six and three months ended June 30, 2013, 120,000 shares of common stock, were paid to the consultant as compensation for services provided. In addition, the Company accrued $30,000 of stock compensation for services provided by this consultant during the timeframe April 1, 2013 to June 30, 2013.

The Company incurred rent expense of $10,023 and $7,596 for the six and three months ended June 30, 2014, respectively. Minimum lease payments for non-cancelable operating leases are as follows:

Future Lease Obligations

	2014 (remaining)	$	9,937
	2015		20,273
	2016		20,881
	2017		7,028
Total future lease obligation		$	58,119

On November 7, 2013, the Company entered into a three-year distribution and supply agreement with Voice of Big Data Solutions, Pvt. Ltd. (“VOBD”) for the distribution of the Company’s 3D facial recognition products in India and Sri Lanka on an exclusive basis and the Middle East and Singapore on a non-exclusive basis. The agreement is subject to termination at any time after the initial three-year term by either the Company or VOBD upon sixty (60) days written notice.

On January 6, 2014, the Company entered into an agreement with a business consulting firm to provide consulting services to the Company for a period of a year. Pursuant to the agreement, the Company agreed to pay the consultant a monthly cash fee of $5,000 and to issue the consultant $5,000 worth of restricted shares of common stock per month as compensation for services provided. During the six and three months ended June 30, 2014, the consultant was issued 7,060 and 3,656 shares, respectively, with an aggregate grant date fair value of $30,000 and $15,000, respectively, and $30,000 and $15,000 in cash for a total aggregate consulting fee of $60,000 and $30,000.

Employment Agreement

Effective October 1, 2012, Nxt-ID entered into an employment agreement with its Chief Executive Officer. The employment agreement provides for:

An initial term of 3 years beginning on October 1, 2012.

An initial base salary of $150,000 per year. In January 2014, upon the successful completion of the MobileWocket prototype, the salary was increased to $300,000 in accordance with the agreement.

Payment of all necessary and reasonable out-of-pocket expenses incurred by the executive in the performance of his duties under the agreement.

Eligibility to participate in bonus or incentive compensation plans that may be established by the board of directors from time to time applicable to the executive's services.

Eligibility to receive equity awards as determined by the board of directors, or a committee of the board of directors, composed in compliance with the corporate governance standards of any applicable listing exchange.

Summary of Significant Accounting Policies (Policies)	6 Months Ended
Summary of Significant Accounting Policies (Policies)	Jun. 30, 2014
Summary of Significant Accounting Policies [Abstract]
USE OF ESTIMATES IN THE FINANCIAL STATEMENTS	*Use of Estimates in the Financial Statements* The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
PRINCIPLES OF CONSOLIDATION	*Principles of Consolidation* The consolidated financial statements include the accounts of Nxt-ID and its wholly-owned subsidiary, 3D-ID. Intercompany balances and transactions have been eliminated upon consolidation.
RESTRICTED CASH	*Restricted Cash* Restricted cash is comprised of amounts held by credit card processors until the Company establishes a history of activity and the processor is able to estimate potential charge back risk. The balances are rolling and held by the processor for a period of less than a year and therefore reported as a current asset on the accompanying condensed consolidated balance sheets.
INVENTORY	*Inventory* Inventory consists principally of raw materials and is valued at the lower of cost or market with cost determined using the first-in, first-out method and with market defined as the lower of replacement cost or realizable value. As of June 30, 2014 inventory is comprised of $29,567 in raw materials on hand. In addition, as an early stage entity, the Company is required to prepay for raw materials with certain vendors until credit terms can be established. As of June 30, 2014, $86,600 of prepaid inventory is included in prepaids on the condensed consolidated balance sheet.
REVENUE RECOGNITION	*Revenue Recognition* The Company’s 3D facial recognition and identification products are currently available for sale and the Company has begun accepting pre-orders on its Mobile Bio Wocket. The Company recognizes revenue in connection with the sale of these products when persuasive evidence of an arrangement exists, the service has been rendered or product delivery has occurred, the price is fixed or readily determinable and collectability of the sale is reasonably assured. As of June 30, 2014, the Company has received $80,075 in customer deposits in connection with pre-orders of its MobileBio Wocket.
CONVERTIBLE INSTRUMENTS	*Convertible Instruments* The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion options. The accounting standards require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (i) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The derivative is subsequently marked to market at each reporting date based on current fair value, with the changes in fair value reported in the results of operations. Conversion options that contain variable settlement features, such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract, generally result in their bifurcation from the host instrument. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 “Debt with Conversion and Other Options.” The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt. See Note 4 below.
DEBT DISCOUNT AND AMORTIZATION OF DEBT DISCOUNT	*Debt discount and amortization of debt discount* Debt discount represents the fair value of embedded conversion options of various convertible debt instruments and attached convertible equity instruments issued in connection with debt instruments. The debt discount is amortized over the earlier of (i) the term of the debt or (ii) conversion of the debt. The amortization of debt discount is included as a component of interest and other expenses, net in the accompanying statements of operations.
INCOME TAXES	*Income Taxes* The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, "Income Taxes." Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity's financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if, based on the weight of the available positive and negative evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. ASC Topic 740-10-30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740-10-40 provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company will classify as income tax expense any interest and penalties. The Company has no material uncertain tax positions for any of the reporting periods presented. Generally, the tax authorities may examine the partnership/corporate tax returns for three years from the date of filing. The Company is in the process of filing its tax returns for the year ended December 31, 2013. Therefore, the Company’s net operating loss carryovers will not be available to offset future taxable income, if any, until the returns are filed.
STOCK-BASED COMPENSATION	*Stock-Based Compensation* The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Non-employee stock-based compensation charges are amortized over the vesting period or as earned.
NET LOSS PER SHARE	*Net Loss per Share* Basic loss per share was computed using the weighted average number of common shares outstanding. Diluted loss per share includes the effect of diluted common stock equivalents. Potentially dilutive securities realizable from the exercise of 1,396,139 warrants as of June 30, 2014 were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. As of June 30, 2013, potentially dilutive securities realizable from the conversion of the Company’s then outstanding note payable into 120,000 shares of common stock and the exercise of warrants for the purchase of 304,600 common shares were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive.
RESEARCH AND DEVELOPMENT	*Research and Development* Research and development costs consist of expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge that would be useful in developing new products or processes. The Company expenses all research and development costs as incurred.

Convertible Notes Payable (Details) - USD ($)		6 Months Ended
Convertible Notes Payable (Details) - USD ($)	Feb. 11, 2014	Jun. 30, 2014	Jun. 30, 2013	Jan. 31, 2013	Dec. 31, 2012
Convertible Notes Payable [Abstract]
Convertible notes payable				$ 75,000	$ 75,000
Convertible notes payable, Maturity date	Dec. 21, 2014
Unamortized debt discount expensed		$ 26,755
Outstanding convertible note converted amount	$ 150,000
Conversion of accrued interest into common stock	$ 21,485
Percentage of discount on closing price	25.00%
Shares issued for debt relief	55,497
Shares issued for debt relief, amount	$ 171,485
Unrealized gain on change in fair value of conversion feature		20,218
Conversion feature in additional paid in capital		$ 98,722
Debt conversion description	CII regarding converting its outstanding convertible note of $150,000, along with accrued interest of $21,485, into common stock at a 25% discount to the Company's closing stock price on February 17, 2014.

Stockholders' Equity (Details) - Warrants [Member]	6 Months Ended
Stockholders' Equity (Details) - Warrants [Member]	Jun. 30, 2014 USD ($) $ / shares shares
Number of Warrants
Number of Warrants Outstanding, beginning \| shares	454,600
Number of Warrants Issued \| shares	1,341,539
Number of Warrants Exercised \| shares	(400,000)
Number of Warrants Cancelled \| shares
Number of Warrants Outstanding, ending \| shares	1,396,139
Number of Warrants Exercisable \| shares	1,396,139
Weighted Average Exercise Price
Weighted Average Exercise Price Outstanding, beginning \| $ / shares	$ 3.23
Weighted Average Exercise Price Issued \| $ / shares	3.00
Weighted Average Exercise Price Exercised \| $ / shares	3.00
Weighted Average Exercise Price Cancelled \| $ / shares
Weighted Average Exercise Price Outstanding, ending \| $ / shares	2.99
Weighted Average Exercise Price Exercisable \| $ / shares	$ 2.99
Weighted Average Remaining Life In Years
Weighted Average Remaining Life In Years Outstanding, beginning	4 years 11 months 19 days
Weighted Average Remaining Life In Years Outstanding, ending	4 years 5 months 27 days
Weighted Average Remaining Life In Years Exercisable	4 years 5 months 27 days
Intrinsic Value
Intrinsic Value Outstanding, Beginning \| $	$ 351,300
Intrinsic Value Outstanding, Ending \| $	1,279,686
Intrinsic Value Exercisable \| $	$ 1,279,686

Stockholders' Equity (Details Textual)		1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
Stockholders' Equity (Details Textual)	Jan. 13, 2014	Feb. 21, 2014 shares	Jan. 31, 2014 USD ($) shares	Jun. 30, 2014 USD ($) directors $ / shares shares	Jun. 30, 2013 shares	Jun. 30, 2014 USD ($) directors $ / shares shares	Jun. 30, 2013 USD ($) shares	Dec. 31, 2013 USD ($) $ / shares shares
Common stock issued \| shares				22,028,285		22,028,285		21,937,822
Common stock, par value \| $ / shares				$ 0.0001		$ 0.0001		$ 0.0001
Gross proceeds in connection with exercise of warrants						$ 1,170,000
Offering costs			$ 100,006					$ 56,820
Warrant received by private placement agent \| shares			41,539
Unrealized gain on derivative liabilities						392,545
Derivative liability - warrants						3,450,976
Remeasured value of warrants						$ 4,589,734
Warrant term	5 years					5 years	5 years
Inducement costs				$ 1,051,128		$ 1,051,128
Restricted shares issued \| shares				2,558		5,084
Restricted shares issued, fair value				$ 10,000		$ 20,000
Number of non executive directors under plan \| directors				2		2
Shares issued to consultants for services \| shares				2,445	120,000	2,445	120,000
Long-term stock incentive plan description						The maximum aggregate number of shares of common stock that may be issued under the LTIP, including stock awards and stock appreciation rights, is limited to 10% of the shares of common stock outstanding on the first business or trading day of any fiscal year, which is 2,193,782 at January 1, 2014.
January 13, 2014 offering [Member]
Closing balance of private offering						$ 1,000,000
Exercised oversubscription amount in offering						350,000
Proceeds from issuance of stock, value						$ 1,350,000
Common stock issued \| shares				415,387		415,387
Common stock, par value \| $ / shares				$ 0.0001		$ 0.0001
Stock sold in private offering, warrant shares \| shares						138,463
Proceeds from private offering						$ 450,000
Securities Purchase Agreement [Member]
Stock sold in private offering, warrant shares \| shares						1,350,000
Common Stock [Member]
Common unit par value \| $ / shares								$ 3.25
Common stock unit under public offering \| shares			276,924					138,463
Retirement of stock by founders, shares \| shares			276,924			400,000		138,463
Proceeds from public offering								$ 450,000
Stock issued under LTIP - shares \| shares						2,193,782
Shares issued to consultants for services \| shares						29,883
Shares issued to consultants for services, fair value						$ 124,000
Warrants [Member]
Proceeds from public offering								$ 900,000
Number of Warrants Exercised \| shares		1,391,539				400,000

Derivative Liabilities (Details) - USD ($)	6 Months Ended
Derivative Liabilities (Details) - USD ($)	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2013
Embedded Conversion Feature:
Fair value		$ 1,650,243	$ 43,324
February 21, 2014
Embedded Conversion Feature:
Risk-free interest rate	1.52%
Expected volatility	105.36%
Expected life (in years)	4 years 10 months 17 days
Expected dividend yield
Number of shares, if converted	1,391,539
Fair value	$ 4,589,734
February 18, 2014
Embedded Conversion Feature:
Risk-free interest rate	0.10%
Expected volatility	105.36%
Expected life (in years)	9 months
Expected dividend yield
Number of shares, if converted	55,497
Fair value	$ 98,722
January 13, 2014
Embedded Conversion Feature:
Risk-free interest rate	1.60%
Expected volatility	123.51%
Expected life (in years)	5 years
Expected dividend yield
Number of shares, if converted	941,539
Fair value	$ 3,450,976
December 31, 2013
Embedded Conversion Feature:
Fair value	$ 1,650,243

Commitments and Contingencies (Details Textual) - USD ($)		1 Months Ended		3 Months Ended		6 Months Ended
	Jan. 06, 2014	Nov. 30, 2013	Oct. 31, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Commitments And Contingencies [Line Items]
consultant fees	$ 5,000	$ 5,000	$ 5,000	$ 112,640		$ 162,767
Shares issued to consultants for services, fair value			10,000	$ 10,000		$ 10,000
Shares issued to consultants for services				2,445	120,000	2,445	120,000
Accrued consultant fees					$ 30,000
Rent expenses				$ 7,596		$ 10,023
Restricted shares issued, fair value				10,000		20,000
Aggregate consulting fee				30,000		60,000
Consultant Agreement [Member]
Commitments And Contingencies [Line Items]
consultant fees	5,000
Shares issued to consultants for services, fair value				$ 15,000		$ 30,000
Shares issued to consultants for services				3,656		7,060
Restricted shares issued, fair value	$ 5,000
Aggregate consulting fee				$ 15,000		$ 30,000
Description on agreement						The agreement is subject to termination at any time after the initial three-year term by either the Company or VOBD upon sixty (60) days written notice.
Employment Agreement [Member]
Commitments And Contingencies [Line Items]
Description on agreement						An initial term of 3 years beginning on October 1, 2012.
Initial base salary			150,000
Increased in salary			$ 300,000

Subsequent Events (Details) - USD ($)						1 Months Ended		3 Months Ended			6 Months Ended		12 Months Ended
Subsequent Events (Details) - USD ($)	Oct. 02, 2014	Sep. 15, 2014	Sep. 12, 2014	Sep. 10, 2014	Aug. 21, 2014	Sep. 30, 2014	Jan. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Subsequent Event [Line Items]
Gross proceeds in connection with exercise of warrants											$ 1,170,000
Offering costs							$ 100,006						$ 56,820
Inducement costs									$ 1,051,128		$ 1,051,128
Shares issued for services									2,445	120,000	2,445	120,000
Common Stock [Member]
Subsequent Event [Line Items]
Retirement of stock by founders, shares							276,924				400,000		138,463
Shares issued for services											29,883
Shares issued for services, fair value											$ 124,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Gross proceeds in connection with exercise of warrants					$ 300,000
Warrant exercise price					$ 3.00
Issuance of warrants					100,000
Retired shares of common stock					100,000
Inducement costs								$ 210,940
Term of lease	3 years		2 years
Lease and rental expense current year	$ 6,365		$ 2,300
Lease and rental expense next year			$ 2,450
Lease expiration term	Jan. 01, 2015
Subsequent Event [Member] \| January 13, 2014 offering [Member]
Subsequent Event [Line Items]
Offering price per share		$ 2.75
Unregistered shares of common stock issued				261,131
Additional inducement expense						$ 718,110
Unregistered shares of common stock issuance expense						$ 232,360
Subsequent Event [Member] \| January 13, 2014 offering [Member] \| Maximum [Member]
Subsequent Event [Line Items]
Warrant exercise price				$ 3.00
Subsequent Event [Member] \| January 13, 2014 offering [Member] \| Minimum [Member]
Subsequent Event [Line Items]
Warrant exercise price				$ 2.00
Subsequent Event [Member] \| Common Stock [Member]
Subsequent Event [Line Items]
Offering price per share		$ 2.75
Stock issued under public offering		2,127,273
Proceeds from public offering		$ 4,954,042
Subsequent Event [Member] \| Warrant [Member]
Subsequent Event [Line Items]
Warrant exercise price		$ 3.288
Offering price per share		$ 2.75
Stock issued under public offering		2,127,273
Warrant date from warrants exercisable		Sep. 15, 2014
Warrants exercisable period		5 years

Convertible Notes Payable	6 Months Ended
Convertible Notes Payable	Jun. 30, 2014
Convertible Notes Payable [Abstract]
CONVERTIBLE NOTES PAYABLE	Note 5 - Convertible Notes Payable On December 13, 2012, the Company received approval from Connecticut Innovations, Inc. (“CII”) for a Convertible Note (the “Note”) in the amount of $150,000. The Company received the first tranche of $75,000 on December 21, 2012 and the second tranche of $75,000 on January 31, 2013. The Note’s maturity date was December 21, 2014. The Company received notice on February 11, 2014 from CII regarding converting its outstanding convertible note of $150,000, along with accrued interest of $21,485, into common stock at a 25% discount to the Company’s closing stock price on February 17, 2014. Since February 17, 2014 was a holiday, the Company used its closing stock price on February 18, 2014 to determine the number of shares issued to CII resulting from the conversion. The Company issued 55,497 shares in full relief of its outstanding debt and accrued interest of $171,485. Since the Note was converted on February 18, 2014, the Company re-measured the conversion feature liability associated with the convertible note payable on that date. The Company recorded an unrealized gain on the change in the fair value of the conversion feature liability of $20,218 for the six months ended June 30, 2014 (see Note 7 below) and reclassified the re-measured conversion feature of $98,722 to additional paid-in capital. Since the Note was converted, the remaining unamortized portion of the debt discount of $26,755 was expensed during the six months ended June 30, 2014.

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2014
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	Note 9 - Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the condensed consolidated financial statements are issued. On August 21, 2014, the Company received proceeds of $300,000 in connection with the exercise of 100,000 warrants into 100,000 shares of common stock at an exercise price of $3.00 per share. The Company determined that the effect of the issuance of the 100,000 warrants was to induce the Purchasers to exercise warrants previously issued to them in the Offering. As a result, the Company recorded an inducement expense of $210,940 for the three months ended September 30, 2014. In connection with the underwritten public offering of the Company’s common stock and warrants on September 15, 2014, the Company was required to obtain a waiver and consent from the investors in the January 13, 2014 private offering in order to conduct the public offering at a price of $2.75 per share and warrant. As a result, on September 10, 2014, the Company issued the majority investors in the January 13, 2014 private offering, 261,131 unregistered shares of common stock and reduced the exercise price on the outstanding warrants from $3.00 to $2.00 per share of common stock for all of the investors. During the three months ended September 30, 2014, the Company recorded additional inducement expense of $718,110 and $232,360 related to the issuance of unregistered shares of common stock to the majority investors and the modification of the warrant exercise price, respectively. On September 12, 2014, the Company entered into a lease agreement for office space in Oxford, Connecticut. The term of the lease is for two (2) years with a monthly rent of $2,300 in the first year, increasing to $2,450 per month in the second year. On September 15, 2014, the Company closed on an underwritten public offering of its common stock and warrants. The Company offered 2,127,273 shares of common stock and warrants to purchase 2,127,273 shares of common stock, at a combined price to the public of $2.75 per share and related warrant. The warrants are exercisable for a period of five (5) years beginning on September 15, 2014 at an exercise price of $3.288 per share. The Company received net proceeds of $4,954,042 from the public offering, after deducting the underwriting discount and other offering related expenses. On October 3, 2014, the Company entered into a lease agreement for warehouse space in Melbourne, Florida. The lease term commences on January 1, 2015. The term of the lease is for three (3) years with a monthly rent amount of $6,365 which includes the base rent, an escrow for taxes and insurance, common area maintenance charges and applicable sale tax.

Organization and Basis of Presentation (Details)	1 Months Ended
Organization and Basis of Presentation (Details)	Jun. 25, 2012 shares
Organisation and Basis of Presentation [Abstract]
Business acquisition, membership interests percentage	100.00%
Common stock acquired in exchange	20,000,000

Going Concern and Management Plans (Details) - USD ($)	3 Months Ended		6 Months Ended
Going Concern and Management Plans (Details) - USD ($)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Going Concern and Management Plans [Abstract]
Net losses	$ (2,090,546)	$ (156,749)	$ (2,228,915)	$ (601,750)
Adjustments to reconcile the net loss to net cash used in operating activities			564,361	$ 297,315
Working capital	263,889		263,889
Stockholders Equity	$ 513,779		513,779		$ (1,831,393)
Proceeds from issuance of common stock and exercise of warrants			$ 1,969,994

Summary of Significant Accounting Policies (Details)	6 Months Ended
Summary of Significant Accounting Policies (Details)	Jun. 30, 2014 USD ($) shares
Potentially dilutive securities \| shares	1,396,139
Prepaid inventory \| $	$ 86,600
Raw materials on hand \| $	30,167
Customer deposits in connection with pre-orders of its MobileBio Wocket \| $	$ 80,075
Conversion of Notes Payable [Member]
Potentially dilutive securities \| shares	120,000
Warrants [Member]
Potentially dilutive securities \| shares	29,567

Restatement (Details) - USD ($)	3 Months Ended			6 Months Ended
Restatement (Details) - USD ($)	Sep. 30, 2014	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Unrealized change in value of the warrants		$ 638,365		$ 638,365
Inducement expense in connection with warrant exercise		(1,051,128)		(1,051,128)
Net loss		(2,090,546)	(156,749)	(2,228,915)	(601,750)
Operating Income (Loss)		$ (1,039,418)	$ (152,249)	(1,559,806)	$ (593,500)
Opeating expenses reduction amount				10,257
Previously reported [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Unrealized change in value of the warrants	$ 2,232,337			2,232,337
Inducement expense in connection with warrant exercise	(1,177,760)			(1,177,760)
Net loss	$ 2,227,435			3,822,887
Operating Income (Loss)				$ 1,049,675

Derivative Liabilities (Details 1) - USD ($)	3 Months Ended	6 Months Ended
Derivative Liabilities (Details 1) - USD ($)	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Beginning liability balance		$ 1,650,243
Recognition of derivative value in equity	$ 44,966	3,450,976	$ 44,966
Net unrealized gain on derivative liabilities in equity		(392,545)
Net unrealized gain onderivative conversion feature liabilities	(1,642)	(20,218)	(1,642)
Adjustment to additional paid in capital upon conversion and modification		$ (4,688,456)
Ending balance	$ 43,324		$ 43,324

Commitments and Contingencies (Details)	Jun. 30, 2014 USD ($)
Commitments and Contingencies [Abstract]
2014 (remaining)	$ 9,937
2015	20,273
2016	20,881
2017	7,028
Total future lease obligation	$ 58,119